Using Whole-Body Vibration Therapy to Improve Gait in Children with Cerebral Palsy
Whole-Body Vibration Therapy in the Gait of Children With Cerebral Palsy
This study is testing if whole-body vibration therapy can help improve walking and movement in children with cerebral palsy who are between 2 and 11 years old.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 2 Years to 11 Years |
| Sex | All |
| Sponsor | Universidad de Almeria Academic / other |
| Locations | 1 site (Almería) |
| Trial ID | NCT06314776 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of whole-body vibration therapy on the gait of children diagnosed with cerebral palsy. It involves comparing the outcomes of usual physiotherapy with and without the addition of vibration therapy. The participants will be children aged 2 to 11 years, classified under GMFCS levels I and II, who are receiving treatment at collaborating centers. The study aims to observe functional improvements in gait and overall mobility.
Who should consider this trial
Good fit: Ideal candidates are children aged 2 to 11 years with a diagnosis of cerebral palsy and classified as GMFCS I or II.
Not a fit: Patients with epilepsy, serious blood circulation issues, or those who have recently undergone surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could enhance mobility and quality of life for children with cerebral palsy.
How similar studies have performed: While the specific application of whole-body vibration therapy in this context is less common, similar studies have shown promising results in improving motor function in children with neurological disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of neurological developmental disorder: Cerebral Palsy. (According to DSM-V) * Age between 2 to 11 years. * GMFCS I and II. * Assessed and/or intervened in or from centers, institutions, etc. who collaborate with the University of Almería or participate in them. Specifically from the "Interactúa" Child Development and Early Care Center. * The subject, father/mother/legal guardian of each subject, prior to inclusion in the study, must have signed the informed consent for the participation of himself or his/her child in it, leaving a record that it could be abandoned if at any time they deem it appropriate and without having to justify it. Exclusion Criteria: * Diagnosis of Epilepsy. * Serious blood circulation problems. * Recent operations. * Prosthetics. * Start of another type of therapy different from the current one. * Not having indication for Physiotherapy.
Where this trial is running
Almería
- María del Mar Sánchez-Joya — Almería, Spain (Recruiting)
Study contacts
- Study coordinator: Maria del Mar Sanchez Joya, PhD
- Email: msj260@ual.es
- Phone: 627445787
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.